NextCure
NXTC
48 hedge funds and large institutions have $25.5M invested in NextCure in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 3 closing their positions.
88% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 8
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
2% more funds holding
Funds holding: 47 → 48 (+1)
0% more call options, than puts
Call options by funds: $2K | Put options by funds: $2K
0.05% less ownership
Funds ownership: 4.82% → 4.77% (-0.05%)
29% less capital invested
Capital invested by funds: $36M → $25.5M (-$10.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
+$932K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$743K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$533K |
| 4 |
Renaissance Technologies
New York
|
+$100K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$74.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.1M |
| 2 |
Morgan Stanley
New York
|
-$652K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$593K |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$393K |
| 5 |
Two Sigma Advisers
New York
|
-$129K |
NXTC Hedge Fund Activity: Q2 2024 in Review
48 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q2 2024, worth a combined $25.5M — down 29% from $36M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NXTC positions and 3 closed out — a net gain of 1 holder — while 15 added to existing stakes and 8 trimmed.
The largest buyer was Logos Global Management, adding an estimated $932K. The largest seller was Millennium Management, cutting an estimated $1.1M.
- 48 institutional investors held NextCure (NXTC) as of Q2 2024, up from 47 in Q1 2024.
- Funds reported $25.5M of NextCure stock for Q2 2024, down 29% quarter-over-quarter.
- 4 funds opened new NextCure positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest NextCure buyer in Q2 2024 was Logos Global Management, an estimated $932K added.
- The largest NextCure seller in Q2 2024 was Millennium Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2024.